Comparative effectiveness of transurethral resection of bladder tumors and office fulguration for recurrent bladder tumors.

Evaluation of: Park DS, Hwang JH, Gong IH et al. An analysis of the efficacy, safety, and cost-effectiveness of fulguration under local anesthesia for small-sized recurrent masses: a comparative analysis of transurethral resection of bladder tumors in a matched cohort. J. Endourol. 27(10), 1240-1244 (2013). At initial diagnosis, most bladder tumors are nonmuscle invasive. Some will recur after initial resection and will require transurethral resections of the bladder tumor. Fulguration under local anesthesia represents an alternative. This option is assessed in the article of Park et al. with respect to efficacy, safety and cost-effectiveness in patients with small-sized recurrent bladder tumors. The authors suggest that fulguration is safe and efficacious without compromising oncological outcomes in selected patients relative to formal transurethral resections of bladder tumor.

[1]  A. Jemal,et al.  Cancer statistics, 2013 , 2013, CA: a cancer journal for clinicians.

[2]  J. Oh,et al.  An analysis of the efficacy, safety, and cost-effectiveness of fulguration under local anesthesia for small-sized recurrent masses: a comparative analysis to transurethral resection of bladder tumors in a matched cohort. , 2013, Journal of endourology.

[3]  S. Shariat,et al.  Cost‐effective treatment of low‐risk carcinoma not invading bladder muscle , 2013, BJU international.

[4]  W. Lowrance,et al.  Office-based Bladder Tumor Fulguration and Surveillance: Indications and Techniques. , 2013, The Urologic clinics of North America.

[5]  G. Dalbagni,et al.  Efficacy of office fulguration for recurrent low grade papillary bladder tumors less than 0.5 cm. , 2004, The Journal of urology.

[6]  B. Birch,et al.  A prospective trial of flexible cystodiathermy for recurrent transitional cell carcinoma of the bladder. , 1999, The Journal of urology.

[7]  M. Babjuk,et al.  ICUD-EAU International Consultation on Bladder Cancer 2012: Non-muscle-invasive urothelial carcinoma of the bladder. , 2013, European urology.

[8]  M. Soloway,et al.  Expectant management of small, recurrent, noninvasive papillary bladder tumors. , 2003, The Journal of urology.

[9]  F. Keeley,et al.  Audit of safety, efficacy, and cost-effectiveness of local anaesthetic cystodiathermy. , 2010, Annals of the Royal College of Surgeons of England.

[10]  E. Wallen,et al.  Conservative management of low risk superficial bladder tumors. , 2008, The Journal of urology.

[11]  M. Benson,et al.  Muscle-invasive urothelial carcinoma of the bladder. , 2007, Urology.